{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:55:47Z","timestamp":1789052147578,"version":"build-2803163510"},"reference-count":191,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2020,9,18]]},"abstract":"<jats:p>There is increasing evidence of central nervous system involvement in numerous neuromuscular disorders primarily considered diseases of skeletal muscle. Our knowledge on cerebral affection in myopathies is expanding continuously due to a better understanding of the genetic background and underlying pathophysiological mechanisms. Intriguingly, there is a remarkable overlap of brain pathology in muscular diseases with pathomechanisms involved in neurodegenerative or neurodevelopmental disorders. A rapid progress in advanced neuroimaging techniques results in further detailed insight into structural and functional cerebral abnormalities. The spectrum of clinical manifestations is broad and includes movement disorders, neurovascular complications, paroxysmal neurological symptoms like migraine and epileptic seizures, but also behavioural abnormalities and cognitive dysfunction. Cerebral involvement implies a high socio-economic and personal burden in adult patients sometimes exceeding the everyday challenges associated with muscle weakness. It is especially important to clarify the nature and natural history of brain affection against the background of upcoming specific treatment regimen in hereditary myopathies that should address the brain as a secondary target. This review aims to highlight the character and extent of central nervous system involvement in patients with hereditary myopathies manifesting in adulthood, however also includes some childhood-onset diseases with brain abnormalities that transfer into adult neurological care.<\/jats:p>","DOI":"10.3233\/jnd-200507","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T12:57:37Z","timestamp":1596545857000},"page":"367-393","source":"Crossref","is-referenced-by-count":10,"title":["Towards Central Nervous System Involvement in Adults with Hereditary Myopathies"],"prefix":"10.1177","volume":"7","author":[{"given":"Jens","family":"Reimann","sequence":"first","affiliation":[{"name":"Department of Neurology, Section of Neuromuscular Diseases, University Hospital Bonn, Germany"},{"name":"Center for Rare Diseases, University Hospital Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Kornblum","sequence":"additional","affiliation":[{"name":"Department of Neurology, Section of Neuromuscular Diseases, University Hospital Bonn, Germany"},{"name":"Center for Rare Diseases, University Hospital Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/JND-200507_ref1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mus.20535","article-title":"Cognitive impairment in neuromuscular disorders","volume":"34","author":"D\u2019Angelo","year":"2006","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.3233\/JND-200507_ref2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/EBC20170108","article-title":"Natural history of mitochondrial disorders: A systematic review","volume":"62","author":"Keshavan","year":"2018","journal-title":"Essays Biochem"},{"issue":"Suppl 1","key":"10.3233\/JND-200507_ref3","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.21037\/t2020.02.02","article-title":"A Clinical Primer on Intellectual Disability","volume":"9","author":"Patel","year":"2020","journal-title":"Transl Pediatr"},{"issue":"8","key":"10.3233\/JND-200507_ref4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1474-4422(10)70159-9","article-title":"The Diagnosis of Young-Onset Dementia","volume":"9","author":"Rossor","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.3233\/JND-200507_ref5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/WNL.53.4.855","article-title":"Age and cause of death in mitochondrial diseases","volume":"53","author":"Klopstock","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JND-200507_ref6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","article-title":"Myotonic dystrophy: Diagnosis, management and new therapies","volume":"27","author":"Turner","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"14","key":"10.3233\/JND-200507_ref7","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.febslet.2006.05.010","article-title":"Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10\/11","volume":"580","author":"McDearmon","year":"2006","journal-title":"FEBS Lett"},{"issue":"12","key":"10.3233\/JND-200507_ref8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/NEN.0b013e318274a128","article-title":"Dystroglycan on Radial Glia Endfeet Is Required For Pial Basement Membrane Integrity and Columnar Organization of the Developing Cerebral Cortex J Neuropathol Exp Neurol","volume":"71","author":"Myshrall","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.3233\/JND-200507_ref9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ana.21482","article-title":"Brain involvement in muscular dystrophies with defective dystroglycan glycosylation","volume":"64","author":"Clement","year":"2008","journal-title":"Ann Neurol"},{"issue":"43","key":"10.3233\/JND-200507_ref10","doi-asserted-by":"publisher","first-page":"14560","DOI":"10.1523\/JNEUROSCI.3247-10.2010","article-title":"Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain","volume":"30","author":"Satz","year":"2010","journal-title":"J Neurosci"},{"issue":"46","key":"10.3233\/JND-200507_ref11","doi-asserted-by":"publisher","first-page":"15260","DOI":"10.1523\/JNEUROSCI.3678-13.2014","article-title":"The extracellular matrix protein laminin \u03b12 regulates the maturation and function of the blood-brain barrier","volume":"34","author":"Menezes","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JND-200507_ref12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/0883073807303219","article-title":"Merosin-negative congenital muscular dystrophy: Diffusion-weighted imaging findings of brain","volume":"22","author":"Alkan","year":"2007","journal-title":"J Child Neurol"},{"issue":"10","key":"10.3233\/JND-200507_ref13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jmg.38.10.649","article-title":"The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: Case series and review","volume":"38","author":"Jones","year":"2001","journal-title":"J Med Genet"},{"issue":"10","key":"10.3233\/JND-200507_ref14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-\u03b12 variome and its related phenotypes","volume":"39","author":"Oliveira","year":"2018","journal-title":"Hum Mutat"},{"issue":"1","key":"10.3233\/JND-200507_ref15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.51.1.101","article-title":"Laminin alpha2 muscular dystrophy: Genotype\/phenotype studies of 22 patients","volume":"51","author":"Pegoraro","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JND-200507_ref16","first-page":"581","article-title":"Abnormal merosin in adults","volume":"121","author":"Bushby","year":"1998","journal-title":"A new form of late onset muscular dystrophy not linked to chromosome 6q2. Brain"},{"key":"10.3233\/JND-200507_ref17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/28653","article-title":"An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy","author":"Kobayashi","year":"1998","journal-title":"Nature"},{"issue":"10","key":"10.3233\/JND-200507_ref18","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/brain\/awm212","article-title":"Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan","volume":"130","author":"Godfrey","year":"2007","journal-title":"Brain"},{"issue":"7","key":"10.3233\/JND-200507_ref19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1212\/WNL.0000000000003609","article-title":"Comparison of brain MRI findings with language and motor function in the dystroglycanopathies","volume":"88","author":"Brun","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.3233\/JND-200507_ref20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s00415-011-5930-3","article-title":"Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I","volume":"258","author":"Palmieri","year":"2011","journal-title":"J Neurol."},{"issue":"10","key":"10.3233\/JND-200507_ref21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJMoa1006939","article-title":"A dystroglycan mutation associated with limb-girdle muscular dystrophy","volume":"364","author":"Hara","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.3233\/JND-200507_ref22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2009.06.006","article-title":"Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies","volume":"85","author":"Lefeber","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"21","key":"10.3233\/JND-200507_ref23","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1093\/hmg\/ddu296","article-title":"POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations","volume":"23","author":"Di Costanzo","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.3233\/JND-200507_ref24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ejhg.2012.71","article-title":"Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy","volume":"20","author":"Bello","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.3233\/JND-200507_ref25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/jmedgenet-2016-104108","article-title":"A novel TRAPPC11 mutation in two Turkish families associated with cerebral atrophy, global retardation, scoliosis, achalasia and alacrima","volume":"54","author":"Koehler","year":"2017","journal-title":"J Med Genet"},{"key":"10.3233\/JND-200507_ref26","unstructured":"Emery AE , Muntoni F , Duchenne Muscular Dystrophy, 3rd ed, Oxford: Oxford University Press, 2003."},{"issue":"4","key":"10.3233\/JND-200507_ref27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/ejhg.2013.169","article-title":"A 3-base pair deletion, c9711_9713del, in DMD results in intellectual disability without muscular dystrophy","volume":"22","author":"de Brouwer","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"10.3233\/JND-200507_ref28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: One gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y","article-title":"Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy?","volume":"80","author":"Moizard","year":"1998","journal-title":"Am J Med Genet"},{"issue":"11","key":"10.3233\/JND-200507_ref30","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/0883073815570154","article-title":"Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy","volume":"30","author":"Banihani","year":"2015","journal-title":"J Child Neurol"},{"issue":"4","key":"10.3233\/JND-200507_ref31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/WNL.55.4.559","article-title":"Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy","volume":"55","author":"Felisari","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JND-200507_ref32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2478\/bjmg-2013-0014","article-title":"Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies","volume":"16","author":"Chamova","year":"2013","journal-title":"Balkan J Med Genet"},{"issue":"3","key":"10.3233\/JND-200507_ref33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.24222","article-title":"Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy","volume":"76","author":"Doorenweerd","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/dmcn.12922","article-title":"Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations","volume":"58","author":"Ricotti","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"20","key":"10.3233\/JND-200507_ref35","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1093\/hmg\/ddp320","article-title":"Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression","volume":"18","author":"Daoud","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.3233\/JND-200507_ref36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.ejhg.5200488","article-title":"Severe cognitive impairment in DMD: Obvious clinical indication for Dp71 isoform point mutation screening","volume":"8","author":"Moizard","year":"2000","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.3233\/JND-200507_ref37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41598-017-12981-5","article-title":"Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy","volume":"7","author":"Doorenweerd","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.3233\/JND-200507_ref38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0960-8966(92)90059-F","article-title":"Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability","volume":"2","author":"Hodgson","year":"1992","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"10.3233\/JND-200507_ref39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/adc.55.8.589","article-title":"Central nervous system involvement in progressive muscular dystrophy","volume":"55","author":"Yoshioka","year":"1980","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.3233\/JND-200507_ref40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0960-8966(99)00108-X","article-title":"Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies","volume":"10","author":"Bardoni","year":"2000","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.3233\/JND-200507_ref41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0883073807307975","article-title":"Cognitive and psychological profile of males with Becker muscular dystrophy","volume":"23","author":"Young","year":"2008","journal-title":"J Child Neurol"},{"issue":"2","key":"10.3233\/JND-200507_ref42","first-page":"98","article-title":"The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy","volume":"240","author":"Bushby","year":"1993","journal-title":"I. Natural history. J Neurol"},{"issue":"12","key":"10.3233\/JND-200507_ref43","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.nmd.2019.09.006","article-title":"Psychiatric and neurodevelopmental aspects of Becker muscular dystrophy","volume":"29","author":"Mori-Yoshimura","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.3233\/JND-200507_ref44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1090-3798(97)80042-6","article-title":"Epilepsy in Duchenne and Becker muscular dystrophies","volume":"1","author":"Goodwin","year":"1997","journal-title":"Eur J Paediatr Neurol"},{"key":"10.3233\/JND-200507_ref45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2015.11.004","article-title":"Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne\/Becker Muscular Dystrophy","volume":"55","author":"Papa","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng709","article-title":"Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome","volume":"29","author":"Zimprich","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"10.3233\/JND-200507_ref47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ejhg.2010.206","article-title":"SGCE isoform characterization and expression in human brain: Implications for myoclonus-dystonia pathogenesis?","volume":"19","author":"Ritz","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.3233\/JND-200507_ref48","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1212\/WNL.0b013e3181b388a3","article-title":"Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes","volume":"73","author":"Blumen","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JND-200507_ref49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00415-011-6255-y","article-title":"Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy","volume":"259","author":"Dubbioso","year":"2012","journal-title":"J Neurol"},{"issue":"3","key":"10.3233\/JND-200507_ref50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.nbd.2004.09.021","article-title":"Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice","volume":"18","author":"Dion","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JND-200507_ref51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2004.09.012","article-title":"RNA pathogenesis of the myotonic dystrophies","volume":"15","author":"Day","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-200507_ref52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mus.20800","article-title":"Cerebral involvement in myotonic dystrophies","volume":"36","author":"Meola","year":"2007","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.3233\/JND-200507_ref53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nmd.2014.01.013","article-title":"Consensus on cerebral involvement in myotonic dystrophy: Workshop report: May 24\u2013 27, Ferrere (AT), Italy","volume":"24","author":"Bugiardini","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-200507_ref54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-510X(75)90252-X","article-title":"Ultrastructure of thalamic neuronal inclusions in myotonic dystrophy","volume":"24","author":"Wi\u015bniewski","year":"1975","journal-title":"J Neurol Sci"},{"key":"10.3233\/JND-200507_ref55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0022-510X(87)90105-5","article-title":"Neuropathological changes of the brain in myotonic dystrophy\u2013some new observations","volume":"81","author":"Ono","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.3233\/JND-200507_ref56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0022-510X(94)90071-X","article-title":"Involvement of the central nervous system in myotonic dystrophy","volume":"127","author":"Abe","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.3233\/JND-200507_ref57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002340050613","article-title":"Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: An MRI and neuropathological study","volume":"40","author":"Ogata","year":"1998","journal-title":"Neuroradiology"},{"key":"10.3233\/JND-200507_ref58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1267\/ahc.10019","article-title":"Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1","volume":"43","author":"Itoh","year":"2010","journal-title":"Acta Histochem Cytochem"},{"key":"10.3233\/JND-200507_ref59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-981-32-9358-8_17","article-title":"Myotonic Dystrophy: An RNA Toxic Gain of Function Tauopathy?","author":"Fernandez-Gomez","year":"1184","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JND-200507_ref60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cortex.2017.08.008","article-title":"The cognitive profile of myotonic dystrophy type A systematic review and meta-analysis","volume":"95","author":"Okkersen","year":"2017","journal-title":"Cortex"},{"issue":"6","key":"10.3233\/JND-200507_ref61","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/mus.24097","article-title":"3rd","volume":"49","author":"Heatwole","year":"2014","journal-title":"Myotonic Dystrophy Health Index: Initial evaluation of a disease-specific outcome measure. Muscle Nerve"},{"issue":"9","key":"10.3233\/JND-200507_ref62","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/WNL.0000000000004300","article-title":"Brain imaging in myotonic dystrophy type A systematic review","volume":"89","author":"Okkersen","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JND-200507_ref63","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fneur.2018.00646","article-title":"Current Progress in CNS Imaging of Myotonic Dystrophy","volume":"9","author":"Minnerop","year":"2018","journal-title":"Front Neurol"},{"key":"10.3233\/JND-200507_ref64","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fneur.2019.01320","article-title":"Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla","volume":"10","author":"Ates","year":"2019","journal-title":"Front Neurol"},{"issue":"2","key":"10.3233\/JND-200507_ref65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mus.24162","article-title":"Transcranial sonography in patients with myotonic dystrophy type 1","volume":"50","author":"Peric","year":"2014","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.3233\/JND-200507_ref66","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00415-014-7566-6","article-title":"Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography","volume":"262","author":"Krogias","year":"2015","journal-title":"J Neurol"},{"issue":"8","key":"10.3233\/JND-200507_ref67","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/brain\/awx153","article-title":"The fatigue conundrum","volume":"140","author":"Kuppuswamy","year":"2017","journal-title":"Brain."},{"key":"10.3233\/JND-200507_ref68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(99)00042-8","article-title":"Excessive daytime sleepiness in myotonic dystrophy","volume":"164","author":"Giubilei","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.3233\/JND-200507_ref69","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/jnn2009.192591","article-title":"Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2","volume":"81","author":"Tieleman","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.3233\/JND-200507_ref70","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/jnn2008.165035","article-title":"A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1","volume":"80","author":"Laberge","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.3233\/JND-200507_ref71","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(18)30203-5","article-title":"Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type A multicentre, single-blind, randomised trial","volume":"17","author":"Okkersen","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.3233\/JND-200507_ref72","doi-asserted-by":"publisher","first-page":"e3810213","DOI":"10.1371\/journal.pone.0213381","article-title":"Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study","volume":"14","author":"Gliem","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JND-200507_ref73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1744-9081-6-25","article-title":"Depression in Myotonic Dystrophy type Clinical and neuronal correlates","volume":"6","author":"Winblad","year":"2010","journal-title":"Behav Brain Funct"},{"issue":"12","key":"10.3233\/JND-200507_ref74","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1093\/brain\/awr299","article-title":"The brain in myotonic dystrophy 1 and Evidence for a predominant white matter disease","volume":"134","author":"Minnerop","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JND-200507_ref75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20301","article-title":"Clinical and molecular aspects of the myotonic dystrophies: A review","volume":"32","author":"Machuca-Tzili","year":"2005","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.3233\/JND-200507_ref76","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","article-title":"Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2)","volume":"13","author":"Meola","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-200507_ref77","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1212\/01.wnl.0000225180.27833.c1","article-title":"Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2)","volume":"67","author":"Gaul","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JND-200507_ref78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10072-007-0742-z","article-title":"Cognitive impairment in adult myotonic dystrophies: A longitudinal study","volume":"28","author":"Sansone","year":"2007","journal-title":"Neurol Sci"},{"key":"10.3233\/JND-200507_ref79","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1212\/WNL.0b013e3181d8c35f","article-title":"Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2","volume":"74","author":"Weber","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.3233\/JND-200507_ref80","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/ene.13062","article-title":"Cognition in myotonic dystrophy type A 5-year follow-up study","volume":"23","author":"Winblad","year":"2016","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.3233\/JND-200507_ref81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nmd.2004.12.003","article-title":"Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1)","volume":"15","author":"Winblad","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.3233\/JND-200507_ref82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jnnp.2005.070763","article-title":"Facial emotion recognition in myotonic dystrophy type 1 correlates with CTG repeat expansion","volume":"77","author":"Winblad","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.3233\/JND-200507_ref83","doi-asserted-by":"publisher","first-page":"e2270204","DOI":"10.1371\/journal.pone.0204227","article-title":"Social cognition in myotonic dystrophy type Specific or secondary impairment?","volume":"13","author":"Labayru","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.3233\/JND-200507_ref84","doi-asserted-by":"publisher","first-page":"e9010156","DOI":"10.1371\/journal.pone.0156901","article-title":"\u201cI Know that You Know that I Know\u201d: Neural Substrates Associated with Social Cognition Deficits in DM1 Patients","volume":"11","author":"Serra","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JND-200507_ref85","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00415-014-7545-y","article-title":"Frontostriatal dysexecutive syndrome: A core cognitive feature of myotonic dystrophy type 2","volume":"262","author":"Peric","year":"2015","journal-title":"J Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.nmd.2016.10.003","article-title":"Cognitive decline over time in adults with myotonic dystrophy type A 9-year longitudinal study","volume":"27","author":"Gallais","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.3233\/JND-200507_ref87","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-004-0408-1","article-title":"Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2","volume":"251","author":"Kornblum","year":"2004","journal-title":"J Neurol"},{"issue":"8","key":"10.3233\/JND-200507_ref88","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s00415-010-5498-3","article-title":"Brain involvement in myotonic dystrophies: Neuroimaging and neuropsychological comparative study in DM1 and DM2","volume":"257","author":"Romeo","year":"2010","journal-title":"J Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref89","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s002340050534","article-title":"The fluid-attenuated inversion-recovery pulse sequence in assessment of central nervous system involvement in myotonic dystrophy","volume":"40","author":"Abe","year":"1998","journal-title":"Neuroradiology"},{"key":"10.3233\/JND-200507_ref90","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nicl.2016.06.011","article-title":"Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1","volume":"12","author":"Baldanzi","year":"2016","journal-title":"NeuroImage Clinical"},{"issue":"4","key":"10.3233\/JND-200507_ref91","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/arclin\/acx008","article-title":"Brain Involvement in Myotonic Dystrophy Type A Morphometric and Diffusion Tensor Imaging Study with Neuropsychological Correlation","volume":"32","author":"Cabada","year":"2017","journal-title":"Archives of clinical neuropsychology: The official journal of the National Academy of Neuropsychologists"},{"issue":"2","key":"10.3233\/JND-200507_ref92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(03)00740-7","article-title":"Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: A controlled 3-dimensional magnetic resonance imaging study","volume":"348","author":"Kassubek","year":"2003","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.3233\/JND-200507_ref93","first-page":"21","article-title":"How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1","volume":"30","author":"Serra","year":"2015","journal-title":"Functional neurology"},{"key":"10.3233\/JND-200507_ref94","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.nicl.2016.04.012","article-title":"Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1","volume":"11","author":"Zanigni","year":"2016","journal-title":"NeuroImage Clinical"},{"issue":"8","key":"10.3233\/JND-200507_ref95","doi-asserted-by":"publisher","first-page":"e971046","DOI":"10.1371\/journal.pone.0104697","article-title":"Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage","volume":"9","author":"Caso","year":"2015","journal-title":"PloS one"},{"issue":"6","key":"10.3233\/JND-200507_ref96","doi-asserted-by":"publisher","first-page":"e3520130","DOI":"10.1371\/journal.pone.0130352","article-title":"Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness","volume":"10","author":"Schneider-Gold","year":"2015","journal-title":"PloS one"},{"issue":"11","key":"10.3233\/JND-200507_ref97","doi-asserted-by":"publisher","first-page":"e3430187","DOI":"10.1371\/journal.pone.0187343","article-title":"Brain gray matter structural network in myotonic dystrophy type 1","volume":"12","author":"Sugiyama","year":"2017","journal-title":"PLoS One"},{"issue":"1-2","key":"10.3233\/JND-200507_ref98","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2014.04.005","article-title":"Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1","volume":"341","author":"Wozniak","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"key":"10.3233\/JND-200507_ref99","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.nicl.2018.101615","article-title":"Structural white matter networks in myotonic dystrophy type 1","volume":"21","author":"van Dorst","year":"2019","journal-title":"Neuroimage Clin"},{"issue":"6","key":"10.3233\/JND-200507_ref100","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10072-010-0406-2","article-title":"Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients","volume":"31","author":"Romeo","year":"2010","journal-title":"Neurol Sci"},{"key":"10.3233\/JND-200507_ref101","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jns.2017.05.013","article-title":"Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2","volume":"378","author":"Peric","year":"2017","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.3233\/JND-200507_ref102","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.53.5.1042","article-title":"Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy","volume":"53","author":"Meola","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-200507_ref103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mus.20565","article-title":"Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1","volume":"34","author":"Vielhaber","year":"2006","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.3233\/JND-200507_ref104","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamaneurol.2014.130","article-title":"Abnormal functional brain connectivity and personality traits in myotonic dystrophy type 1","volume":"71","author":"Serra","year":"2014","journal-title":"JAMA Neurology"},{"issue":"1","key":"10.3233\/JND-200507_ref105","first-page":"14","article-title":"Personality traits in patients with myotonic dystrophy type 2","volume":"36","author":"Paunic","year":"2017","journal-title":"Acta Myol"},{"issue":"1","key":"10.3233\/JND-200507_ref106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.48.1.33","article-title":"Proximal myotonic myopathy with MRI white matter abnormalities of the brain","volume":"48","author":"Hund","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JND-200507_ref107","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.24927","article-title":"Brain sonography insight into the midbrain in myotonic dystrophy type 2","volume":"53","author":"Rakocevic-Stojanovic","year":"2016","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.3233\/JND-200507_ref108","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s00415-008-0997-1","article-title":"Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2","volume":"255","author":"Minnerop","year":"2008","journal-title":"J Neurol"},{"issue":"6","key":"10.3233\/JND-200507_ref109","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ejhg.2014.191","article-title":"Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1","volume":"23","author":"Larsen","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.3233\/JND-200507_ref110","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.10057","article-title":"Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis","volume":"50","author":"Lemmers","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JND-200507_ref111","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1002\/mus.880181313","article-title":"Early onset facioscapulohumeral muscular dystrophy","author":"Brouwer","year":"1995","journal-title":"Muscle Nerve Suppl"},{"issue":"16","key":"10.3233\/JND-200507_ref112","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1212\/WNL.0b013e3182a84140","article-title":"Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy","volume":"81","author":"Lutz","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JND-200507_ref113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00439401","article-title":"Hearing loss in facioscapulohumeral dystrophy","volume":"145","author":"Voit","year":"1986","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.3233\/JND-200507_ref114","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1468-1331.2008.02314.x","article-title":"Facioscapulohumeral muscular dystrophy: Hearing loss and other atypical features of patients with large 4q35 deletions","volume":"15","author":"Trevisan","year":"2008","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000107431","article-title":"Facioscapulohumeral muscular dystrophy: A multicenter study on hearing function","volume":"13","author":"Trevisan","year":"2008","journal-title":"Audiol Neurootol"},{"issue":"6","key":"10.3233\/JND-200507_ref116","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0404.1997.tb00223.x","article-title":"Evoked potential study in facio-scapulo-humeral muscular dystrophy","volume":"95","author":"Fierro","year":"1997","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.3233\/JND-200507_ref117","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.neuroimage.2006.04.226","article-title":"Modifications of brain tissue volumes in facioscapulohumeral dystrophy","volume":"32","author":"Quarantelli","year":"2006","journal-title":"Neuroimage"},{"issue":"6","key":"10.3233\/JND-200507_ref118","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M","article-title":"Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype","volume":"45","author":"Ricci","year":"1999","journal-title":"Ann Neurol"},{"issue":"12","key":"10.3233\/JND-200507_ref119","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"issue":"17","key":"10.3233\/JND-200507_ref120","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181f96175","article-title":"Clinical features of facioscapulohumeral muscular dystrophy 2","volume":"75","author":"de Greef","year":"2010","journal-title":"Neurology"},{"issue":"8","key":"10.3233\/JND-200507_ref121","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrneurol.2013","article-title":"The clinical maze of mitochondrial neurology","volume":"9","author":"DiMauro","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.3233\/JND-200507_ref122","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JND-200507_ref123","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02002711","article-title":"Clinical presentations and laboratory investigations in respiratory chain deficiency","author":"Munnich","year":"1996","journal-title":"Eur J Pediatr. 155"},{"issue":"11","key":"10.3233\/JND-200507_ref124","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00381-016-3190-3","article-title":"The many faces of paediatric mitochondrial disease on neuroimaging","volume":"32","author":"Baertling","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.3233\/JND-200507_ref125","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/nan.12333","article-title":"Review: Central nervous system involvement in mitochondrial disease","volume":"43","author":"Lax","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.3233\/JND-200507_ref126","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1552-6569.2011.00693.x","article-title":"Leukoencephalopathies in mitochondrial disorders: Clinical and MRI findings","volume":"22","author":"Finsterer","year":"2012","journal-title":"J Neuroimaging"},{"issue":"1-3","key":"10.3233\/JND-200507_ref127","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10540-007-9034-3","article-title":"Neuropathology of mitochondrial diseases","volume":"27","author":"Filosto","year":"2007","journal-title":"Biosci Rep"},{"issue":"9","key":"10.3233\/JND-200507_ref128","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1474-4422(15)00148-9","article-title":"Mitochondrial dysfunction and seizures: The neuronal energy crisis","volume":"14","author":"Zsurka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"Suppl. 4","key":"10.3233\/JND-200507_ref129","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1528-1167.2012.03618.x","article-title":"Mitochondrial disease and epilepsy","volume":"53","author":"Bindoff LA and Engelsen","year":"2012","journal-title":"Epilepsia"},{"issue":"10","key":"10.3233\/JND-200507_ref130","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.56.10.1340","article-title":"Epileptic phenotypes associated with mitochondrial disorders","volume":"56","author":"Canafoglia","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JND-200507_ref131","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/01.wnl.0000182814.55361.70","article-title":"POLG mutations in Alpers syndrome","volume":"65","author":"Nguyen","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.3233\/JND-200507_ref132","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1212\/WNL.0b013e3181cef7ab","article-title":"Severe epilepsy as the major symptom of new mutations in the mitochondrial tRNAPhe gene","volume":"74","author":"Zsurka","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JND-200507_ref133","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/brain\/awn007","article-title":"POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection","volume":"131","author":"Engelsen","year":"2008","journal-title":"Brain"},{"key":"10.3233\/JND-200507_ref134","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/brain\/awl097","article-title":"The spectrum of clinical disease caused by the A467T and W748S POLG mutations: A study of 26 cases","volume":"129","author":"Tzoulis","year":"2006","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JND-200507_ref135","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","article-title":"POLG-related disorders and their neurological manifestations","volume":"15","author":"Rahman","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.3233\/JND-200507_ref136","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/ene.13003","article-title":"ADCK3 mutations with epilepsy, stroke-like episodes and ataxia: A POLG mimic?","volume":"23","author":"Hikmat","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.3233\/JND-200507_ref137","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","article-title":"Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency","volume":"38","author":"Desbats","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.3233\/JND-200507_ref138","doi-asserted-by":"publisher","first-page":"201","DOI":"10.12688\/wellcomeopenres.15599.1","article-title":"Consensus-based statements for the management of mitochondrial stroke-like episodes [version 1; peer review: 1 approved] Wellcome Open Research","volume":"4","author":"Ng","year":"2019","journal-title":"201"},{"issue":"2","key":"10.3233\/JND-200507_ref139","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jnnp-2011-301258","article-title":"Adult-onset cerebellar ataxia due to mutations in CABC1\/ADCK3","volume":"83","author":"Horvath","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JND-200507_ref140","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1212\/01.WNL.0000156516.77696.5A","article-title":"Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations","volume":"64","author":"Winterthun","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JND-200507_ref141","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00415-016-8086-3","article-title":"Expanded phenotypic spectrum of the m","volume":"263","author":"Altmann","year":"2016","journal-title":"A>G \u201cMERRF\u201d mutation: Data from the German mitoNET registry. J Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref142","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1212\/NXG.0000000000000393","article-title":"Delineating MT-ATP6-associated disease: From isolated neuropathy to early onset neurodegeneration","volume":"6","author":"Stendel","year":"2020","journal-title":"Neurol Genet"},{"issue":"2","key":"10.3233\/JND-200507_ref143","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ana.25525","article-title":"Pathogenic variants in MT-ATP A United Kingdom-based mitochondrial disease cohort study","volume":"86","author":"Ng","year":"2019","journal-title":"Ann Neurol"},{"key":"10.3233\/JND-200507_ref144","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0140-6736(88)91632-7","article-title":"Kearns-Sayre syndrome with muscle mitochondrial DNA deletion","volume":"1","author":"Lestienne","year":"1988","journal-title":"Lancet"},{"key":"10.3233\/JND-200507_ref145","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM198905183202001","article-title":"Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome","volume":"320","author":"Moraes","year":"1989","journal-title":"N Engl J Med"},{"key":"10.3233\/JND-200507_ref146","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"issue":"9","key":"10.3233\/JND-200507_ref147","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1212\/WNL.53.9.2182","article-title":"Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging","volume":"53","author":"Yoneda","year":"1999","journal-title":"Neurology"},{"issue":"1-2","key":"10.3233\/JND-200507_ref148","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"9437","key":"10.3233\/JND-200507_ref149","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","article-title":"Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: Clinical and molecular genetic study","volume":"364","author":"Luoma","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.3233\/JND-200507_ref150","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/mds.22135","article-title":"Apraxia of lid opening mimicking ptosis in compound heterozygosity for A467T and W748S POLG1 mutations","volume":"23","author":"Paus","year":"2008","journal-title":"Mov Disord"},{"issue":"3","key":"10.3233\/JND-200507_ref151","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/mds.26966","article-title":"Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson\u2019s disease","volume":"32","author":"Giannoccaro","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"10.3233\/JND-200507_ref152","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: A case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.3233\/JND-200507_ref153","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ene.14068","article-title":"Systematic review of cognitive deficits in adult mitochondrial disease","volume":"27","author":"Moore","year":"2020","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.3233\/JND-200507_ref154","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/brain\/awg101","article-title":"Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome","volume":"126","author":"Bosbach","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JND-200507_ref155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/WNN.0b013e3180335faf","article-title":"The neuropsychologic deficits of MELAS: Evidence of global impairment","volume":"20","author":"Neargarder","year":"2007","journal-title":"Cogn Behav Neurol"},{"issue":"1","key":"10.3233\/JND-200507_ref156","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/head.13219","article-title":"Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study","volume":"58","author":"Kraya","year":"2018","journal-title":"Headache"},{"key":"10.3233\/JND-200507_ref157","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clineuro.2018.01.020","article-title":"Headache in mitochondrial disorders","volume":"166","author":"Finsterer","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.3233\/JND-200507_ref158","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/EBC20170109","article-title":"Neuroimaging in mitochondrial disorders","volume":"62","author":"Mascalchi","year":"2018","journal-title":"Essays Biochem"},{"issue":"4","key":"10.3233\/JND-200507_ref159","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/brain\/awu026","article-title":"Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: Clinical and genetic characterization and target for therapy","volume":"137","author":"van Berge","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JND-200507_ref160","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11689-019-9292-y","article-title":"Mitochondrial aminoacyl-tRNA synthetase disorders: An emerging group of developmental disorders of myelination","volume":"11","author":"Fine","year":"2019","journal-title":"J Neurodev Disord"},{"issue":"4","key":"10.3233\/JND-200507_ref161","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00415-012-6763-4","article-title":"Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.A>G MTTL1 mutation","volume":"260","author":"Tschampa","year":"2013","journal-title":"J Neurol"},{"key":"10.3233\/JND-200507_ref162","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","article-title":"Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder","volume":"283","author":"Nishino","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.3233\/JND-200507_ref163","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: A 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur J Neurol"},{"issue":"13","key":"10.3233\/JND-200507_ref164","doi-asserted-by":"publisher","first-page":"284","DOI":"10.21037\/atm.2019.07.24","article-title":"Multisystem late onset Pompe disease (LOPD): An update on clinical aspects","volume":"7","author":"Toscano","year":"2019","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.3233\/JND-200507_ref165","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13023-018-0794-6","article-title":"Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease","volume":"13","author":"Hensel","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.3233\/JND-200507_ref166","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ene.13835","article-title":"Central nervous system involvement in late-onset Pompe disease: Clues from neuroimaging and neuropsychological analysis","volume":"26","author":"Musumeci","year":"2019","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.3233\/JND-200507_ref167","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/dmcn.13740","article-title":"Classic infantile Pompe patients approaching adulthood: A cohort study on consequences for the brain","volume":"60","author":"Ebbink","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"13","key":"10.3233\/JND-200507_ref168","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/atm.2019.05.56","article-title":"Pompe disease gene therapy: Neural manifestations require consideration of CNS directed therapy","volume":"7","author":"Byrne","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.3233\/JND-200507_ref169","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-015-0264-3","article-title":"Rhabdomyolysis: A genetic perspective","volume":"10","author":"Scalco","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.3233\/JND-200507_ref170","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.21612","article-title":"Myopathy and parkinsonism in phosphoglycerate kinase deficiency","volume":"41","author":"Sotiriou","year":"2010","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.3233\/JND-200507_ref171","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nmd.2008.12.004","article-title":"Myopathic form of phosphoglycerate kinase (PGK) deficiency: A new case and pathogenic considerations","volume":"19","author":"Spiegel","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.3233\/JND-200507_ref172","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/088307388900400203","article-title":"Recurrent myoglobinuria in a child with mental retardation: Phosphoglycerate kinase deficiency","volume":"4","author":"Sugie","year":"1989","journal-title":"J Child Neurol"},{"issue":"5","key":"10.3233\/JND-200507_ref173","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nmd.2009.02.012","article-title":"Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget\u2019s disease of bone and frontotemporal dementia","volume":"19","author":"Stojkovic","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.3233\/JND-200507_ref174","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.13095","article-title":"Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy","volume":"93","author":"Al-Obeidi","year":"2018","journal-title":"Clin Genet"},{"issue":"5","key":"10.3233\/JND-200507_ref175","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"issue":"9","key":"10.3233\/JND-200507_ref176","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2012.04.005","article-title":"Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis","volume":"33","author":"Abramzon","year":"2231","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JND-200507_ref177","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1017\/S1462399409001136","article-title":"The molecular basis of frontotemporal dementia","volume":"11","author":"Neumann","year":"2009","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"10.3233\/JND-200507_ref178","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5414\/NPP26232","article-title":"Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein","volume":"26","author":"Krause","year":"2007","journal-title":"Clin Neuropathol"},{"issue":"3","key":"10.3233\/JND-200507_ref179","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00415-010-5774-2","article-title":"Early signs of VCP-related frontotemporal dementia: A neuropsychological, FDG-PET and fMRI study","volume":"258","author":"Kalbe","year":"2011","journal-title":"J Neurol"},{"key":"10.3233\/JND-200507_ref180","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1750-1172-6-68","article-title":"Neuroacanthocytosis syndromes","volume":"6","author":"Jung","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.3233\/JND-200507_ref181","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mus.10199","article-title":"Malignant McLeod myopathy","volume":"26","author":"Jung","year":"2002","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.3233\/JND-200507_ref182","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1097-4598(200007)23:7<1113::aid-mus15>3.0.co;2-6","article-title":"Muscle CT scan findings in McLeod syndrome and chorea-acanthocytosis","volume":"23","author":"Ishikawa","year":"2000","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.3233\/JND-200507_ref183","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1093\/brain\/awm269","article-title":"McLeod myopathy revisited: More neurogenic and less benign","volume":"130","author":"Hewer","year":"2007","journal-title":"Brain"},{"key":"10.3233\/JND-200507_ref184","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1423-0410.1961.tb03203.x","article-title":"A new phenotype (McLeod) in the Kell blood-group system","volume":"6","author":"Allen","year":"1961","journal-title":"Vox Sang."},{"issue":"2","key":"10.3233\/JND-200507_ref185","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ana.20200","article-title":"Chorein detection for the diagnosis of chorea-acanthocytosis","volume":"56","author":"Dobson-Stone","year":"2004","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JND-200507_ref186","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1537-2995.2007.01106.x","article-title":"McLeod phenotype without the McLeod syndrome","volume":"47","author":"Walker","year":"2007","journal-title":"Transfusion"},{"issue":"6","key":"10.3233\/JND-200507_ref187","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ana.10035","article-title":"McLeod neuroacanthocytosis: Genotype and phenotype","volume":"50","author":"Danek","year":"2001","journal-title":"Ann Neurol"},{"key":"10.3233\/JND-200507_ref188","first-page":"1993","volume-title":"GeneReviews\u00ae [Internet]","author":"Velayos Baeza","year":"2002"},{"issue":"4","key":"10.3233\/JND-200507_ref189","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.seizure.2010.12.007","article-title":"Bilateral temporal lobe epilepsy confirmed with intracranial EEG in chorea-acanthocytosis","volume":"20","author":"Bader","year":"2011","journal-title":"Seizure"},{"issue":"5","key":"10.3233\/JND-200507_ref190","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neubiorev.2011.01.001","article-title":"The neuropsychiatry of neuroacanthocytosis syndromes","volume":"35","author":"Walterfang","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.3233\/JND-200507_ref191","first-page":"250","article-title":"Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome","volume":"37","author":"Francke","year":"1985","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-200507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:30Z","timestamp":1777506570000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-200507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":191,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jnd-200507","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}